A b s t r a c t
Most soft tissue tumors metastasize to the pulmonary bed during their clinical evolution, 1 although liposarcomas are reported to have a tendency to spread to extrapulmonary sites. 2 Studies have shown that this predilection to extrapulmonary metastasis is true for myxoid liposarcoma (ML) only, [3] [4] [5] not for pleomorphic liposarcoma (PL) 4, 6 and dedifferentiated liposarcoma (DDL). 4, 7 The other type of liposarcoma, atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL), is not expected to metastasize unless dedifferentiation occurs. 4, 7, 8 Like other tumors, 9 the metastatic foci of liposarcoma might differ in histologic features from the primary tumor and often are more cellular with fewer lipoblasts or even nonlipogenic. 4 We have encountered a few cases in which the pulmonary metastasis did not resemble the primary tumor. During the early phase of the specimen workup, the information about resection of primary adipose tumor was not disclosed; therefore, the list of entities considered was necessarily long. There seems to be a significant difference in prognosis between liposarcoma with lung metastasis and nonlipogenic sarcomas with lung metastasis. 10 The latter group has more aggressive behavior, demanding an accurate histopathologic diagnosis.
The present study was undertaken to describe the histologic spectrum of pulmonary metastasis from liposarcomas and the clinical implications of the different histomorphologic features of these metastatic foci.
Materials and Methods
All cases diagnosed as liposarcoma with pulmonary metastasis seen at the departments of pathology at the University of Texas M.D. Anderson Cancer Center, Houston, and Ohio State University, Columbus, from January 1988 to December 2003 were retrieved. All available materials, including H&E-stained sections, conventional stains, and immunohistochemical stains, were reviewed. If original materials were not in the file, recuts from stored paraffin blocks were examined for primary and metastatic tumors. Clinical information was obtained from medical records and contributing physicians.
The histologic type of liposarcoma, site of primary tumor, sites of metastasis, interval between diagnosis of primary tumor and appearance of metastasis, treatment, length of follow-up (from date of first histopathologic diagnosis), and status at last follow-up were recorded. Most of the terms used in the present study are defined based on the 2002 World Health Organization classification of tumors of soft tissue and bone. 11 ALT/WDL is a locally infiltrative lipogenic tumor composed of mature fat and scattered atypical stromal cells. DDL is a nonlipogenic tumor arising from ALT/WDL de novo or as a recurrence from a previously resected ALT/WDL; dedifferentiation is recognized as low grade when lesional cells are spindle-shaped and with minimal atypia and high grade when there is considerable atypia resembling fibrosarcoma or an undifferentiated pleomorphic sarcoma. 3 Round cell liposarcoma (RCL) is used synonymously with cellular ML and considered a variant of ML. An area of ML is deemed to represent RCL/cellular ML when it is hypercellular and the cells are closely apposed with minimal or no intervening space between cells and the characteristic vascular pattern is inconspicuous. 3 PL is a mesenchymal neoplasm with lipoblasts and other lesional cells with atypia approximating that of malignant fibrous histiocytosis (MFH) or its variants. 3 
Results
Thirty cases of liposarcoma during this period had resection of 1 or more metastatic tumors to the lungs. Of the 30 cases, 6 were excluded owing to inadequate clinical history. A total of 24 cases representing 8 cases each of ML, PL, and DDL formed the study population.
Myxoid Liposarcoma

Clinicopathologic Features
The patients were predominantly men (M/F ratio, 7:1) ❚Table 1❚. The patients' ages ranged from 31 to 61 years (mean, 45.9 years). The primary sites were gluteal and groin areas (4) and lower extremity (4) . All primary tumors were resected. The status of the margin of resection and additional treatments are summarized in Table 1 .
Metastatic Tumors to the Lungs
The lungs were the initial site of metastasis in 6 cases and the only metastatic site in 3 ❚Table 2❚. The initial lung metastases were solitary in 3 cases ❚Image 1❚ and 3 or more in 5 cases.
Initial metastatic tumor was seen in all lobes of the lung, except right middle lobe. The left lower lobe was involved in 3 cases and the right upper lobe, right lower lobe, and left upper lobe at least once. Three cases had both lungs involved by tumor, but the lobe was not specified ( Table 2 ). The number of nodules resected ranged from 1 to 7 per patient.
In 4 cases, typical ML histologic features were observed as small foci in a tumor or representing the entire tumor. Cellular ML (RCL) was the sole or predominant type in 2 cases and was seen as small foci in 1 case. In 3 patients who received neoadjuvant chemotherapy, extensively hyalinized and hypocellular tumor, changes considered treatment-related, were seen in 2 patients; the third patient had minimal treatment effect (case 3) ❚Table 3❚.
In all metastatic nodules, the component tumor cells were relatively uniform without considerable variation in size and shape of cells. Lipoblasts were seen in 3 cases and were of the signet-ring type (Table 3 ) ❚Image 2❚ and ❚Image 3❚.
The outline of each metastatic nodule appeared well circumscribed. The central portion of the nodules often was the least cellular area, and, frequently, the viable-looking tumor cells were concentrated at the periphery of the nodules. At the periphery of the nodules, both tumor cells and hyalinized parts of the nodule expanded the lung interstitium, often appearing as bulbous papillae protruding into the alveolar spaces covered by hyperplastic alveolar epithelium. Singly scattered or clusters of infiltrating tumor cells were observed rarely. Lymphovascular invasion was not identified. In 1 case of nonlipogenic cellular ML (case 6), the component cells were arranged in a vague nesting pattern with round cells and discrete hyalinization resembling melanoma and/or a neuroendocrine neoplasm. In addition, owing to the partly myxoid stroma, epithelioid hemangioendothelioma also was considered as a diagnosis. These entities were ruled out owing to nonreactivity of tumor cells to antibodies against cytokeratin, S-100 protein, CD34, and CD31 by immunohistochemical analysis.
Clinical Course
The follow-up period ranged from 31 to 168 months (mean, 71.6 months) ( Table 2 ). Two patients (cases 3 and 6) had no evidence of disease after resection of lung metastasis at 58 and 102 months of follow-up. One patient (case 4) died of disease 92 months after diagnosis of primary tumor, 4 patients had progressive disease at 36 to 168 months of follow-up, and 1 patient (case 1) had stable disease assessed after 42 months of follow-up.
Pleomorphic Liposarcoma
Clinicopathologic Features
All 8 cases of PL involved male patients ❚Table 4❚. Their ages ranged from 14 to 58 years (mean, 42.8 years). The primary sites involved different anatomic areas. All primary tumors were resected. The status of margin of resection and additional treatments are summarized in Table 4 .
Metastatic Tumors to the Lungs
The lungs were the initial site of metastasis in 7 of 8 patients ❚Table 5❚. There was 1 metastatic focus in 2 patients, 2 metastatic foci in 2, and multiple metastatic foci in 4 ❚Image 1❚ Liposarcoma metastatic to lung parenchyma.
lung lobes had 2 metastatic foci each; 1 had bilateral lung metastasis (involved lung lobes were not specified). Of 8 cases, 6 were nonlipogenic. All metastatic nodules consisted predominantly of medium to large lesional cells with variable numbers of pleomorphic cells, including bizarre and giant cells. Mitoses were numerous. Three cases had tumor necrosis. Considerable myxoid background was present in 3 cases. Of the 2 lipogenic tumors, 1 (case 4) had numerous signet-ring lipoblasts with scattered pleomorphic forms ❚Image 4❚ and ❚Image 5❚. Of the 4 postchemotherapy cases, 2 had extensive stromal hyalinization. Often, the periphery of the nodules was made irregular by invading tumor, dispersed in single cells or in tight clusters. Hyperplastic alveolar epithelium as seen in ML was seen Metastatic melanoma was considered and ruled out in 2 tumors (cases 6 and 7). Both tumors were negative for S-100 protein and HMB-45; case 7 also was negative for MART-1.
Clinical Course
One patient (case 5) had no evidence of disease after 42 months of follow-up (36 months after resection of 2 lung metastases) (Table 5 ). Another patient (case 6) had stable disease assessed 3 months after resection of lung metastasis and 15 months after resection of the primary tumor; this patient had multiple metastases involving only the lungs. The other 6 patients had multiple metastases with progressive disease at last follow-up. In 5 of these 6 patients, multiple pulmonary and extrapulmonary metastases developed subsequently after the initial pulmonary metastasis. One patient (case 8) had local recurrence (mediastinum) 3 months after excision of the primary tumor.
Dedifferentiated Liposarcoma
Clinicopathologic Features
The patients were predominantly men (M/F ratio,7:1). Their ages ranged from 37 to 77 years (mean, 58.4 years). Primary sites were distributed as follows: retroperitoneum, 4; mediastinum, 2; and scrotum or spermatic cord, 2. All primary tumors were resected. The status of margin of resection and additional treatments are summarized in ❚Table 7❚.
De novo DDL was present in 5 cases. Three patients (cases 1, 2, and 6) had an original diagnosis of ALT/WDL at the primary site, and a diagnosis of DDL was established based on the histologic features of the lung metastasis. All 3 patients had local recurrence. One patient (case 6) had recurrence of "hernia" at the scrotal area with eventual histologic findings of a dedifferentiated component on the third resection, 34 months after the first "herniorrhaphy" ❚Table 8❚. 
Metastatic Tumors to the Lungs
The lungs were the initial site of metastasis in all cases and the only site of metastasis in 3 cases (Table 8 ). The initial lung metastases ranged from single to multiple foci. One metastatic focus was seen in 6 patients, and multiple foci were seen in 2 patients. All metastases involved the left lung: left upper lobe, 2; left lower lobe, 4; "left lung," 1; and bilateral, 1. The maximum number of metastatic nodules resected from a patient was 5.
All 8 metastatic nodules were nonlipogenic ❚Table 9❚. The histomorphologic features in 3 patients (cases 6, 7, and 8) were those of MFH composed of pleomorphic cells with admixed bizarre giant cells and multinucleated cells ❚Image 6❚. Rhabdomyosarcomatous differentiation was present in 1 (case 6). Of the 5 nodules resected from case 7, 4 were cellular and 1 was hypocellular and extensively hyalinized. The tumor of the third patient (case 8) had no specific mesenchymal histologic features and was consistent with undifferentiated high-grade pleomorphic sarcoma. 12 Of these 3 patients, 2 received preresection chemotherapy, including the patient (case 8) with a hyalinized and partly necrotic tumor nodule.
One patient (case 1) had features of fibroblastic osteosarcoma consisting of spindle cells in fascicles alternating with well-formed bone matrix lined by osteoblasts. Two other patients (cases 2 and 4) had spindle cell sarcoma; both tumors had interlacing short fascicles of noticeably atypical spindle cells with a subtle storiform pattern.
The outline of the metastatic nodules was jagged as a result of tumor cells infiltrating into the lung parenchyma, a feature similar to those seen in metastatic nodules of PL. Tumor infiltration was less conspicuous in the spindle cell sarcomatous nodules, including that of the fibroblastic osteosarcoma ❚Image 4❚ Low-power view of a pleomorphic liposarcoma metastatic to the lung (H&E, ×30).
❚Image 5❚ High-power view of a pleomorphic liposarcoma metastatic to the lung (H&E, ×40). type. The hyperplastic alveolar epithelium seen around nodules of metastatic ML sometimes was seen at the periphery of DDL nodules.
Clinical Course
In 6 of 8 patients, there were additional multiple lung metastases 10 to 277 months after the initial lung metastasis (Table 8 ). Metastasis to nonpulmonary sites appeared in 5 patients 0 to 277 months after the appearance of dedifferentiated morphologic features from the primary site or metastasis.
Of 8 patients, 7 had local recurrence 8 to 116 months after the primary diagnosis. All 8 patients had progressive disease, 7 from local recurrence and metastatic disease and 1 from local recurrence only (case 1).
Interval to Pulmonary and Extrapulmonary Metastasis
The appearance of initial lung metastasis from the time of diagnosis of the primary tumor was considerably shorter for PL at 0 to 107 months (mean, 23 months) than for DDL (range, 0-277 months; mean, 51 months) and ML (range, 5-144 months; mean, 53 months) ❚Table 10❚. The occurrence of the first extrapulmonary metastasis also was earlier for PL at 10 to 130 months (mean, 43 months) than DDL (range, 24-277 months; mean, 72 months) and ML (range, 12-158 months; mean, 65 months) (Table 10) .
Discussion
In this series of 24 cases of liposarcoma metastatic to the lungs, the majority of patients were male. Although PL and ML cases were distributed randomly among the lung lobes, there was unexplained overrepresentation of the left lung, particularly the left lower lobe, as a site of metastasis for DDL. The lower lobe predilection might be due to increased blood flow to that area, 13, 14 but the left laterality is unexplained. In contrast, a large series of melanoma metastatic to the lungs favored the right side over the left. 15 In all of the metastatic ML to the lungs, the tumor outline was well circumscribed. There were no infiltrating tumor cells at the periphery, and the protruding nests of tumor cells were covered by reactive alveolar epithelium. These changes were interpreted as a sign of a relatively slower tumor growth, thereby permitting some reaction from surrounding tissue. For most ML tumors resected after adjuvant chemotherapy, treatment-related changes such as hypocellularity and extensive hyalinization were prominent. The quantity of cellular areas in ML (RCL) has been used to predict the clinical behavior of ML 3, 5, 16, 17 and proved to be an important prognostic factor. Because these histologic features are based on the primary tumor, it is not known whether they have any meaning if applied to metastatic tumors such as those in the lungs. The cellularity of metastatic ML more often is increased than decreased. 4 The evaluation of these metastatic tumors is confounded by therapy-related changes precluding the estimation of true cellularity and cytologic appearance of neoplastic cells. Moreover, evidence of therapy-related effects does ❚Image 6❚ Dedifferentiated liposarcoma (high-grade sarcoma) (H&E, ×40). not necessarily translate into better clinical outcome. Two patients in our series had extensive treatment-related changes but had progressive disease. On the other hand, 2 patients with typical ML and cellular ML had not received chemotherapy but were disease-free 10 and 20 months after pulmonary metastasectomy, respectively. These findings suggest that histologically chemotherapy-responsive metastatic ML should be interpreted with caution because disease progression still is possible. Furthermore, it is well known that ML metastasizes to lungs and other organs many years after the diagnosis of primary tumor. 2, 3 Other clinical and pathologic factors shown to influence survival, including location and histologic features of the primary tumor, resectability of the primary and metastatic tumors, length of the disease-free interval, and patient's age, also should be considered when assessing the prognosis. [18] [19] [20] The differential diagnosis is of real concern only when the metastatic lesion is solitary and the clinical history is not provided.
The scarcity or absence of viable cells in treated tumors might lead to the consideration of a benign process such as myxoid hamartoma instead of recognition of a treated tumor. In this setting, it is worthwhile to submit additional sections from the tumor to disclose typical areas of ML.
Prominence of myxoid component, a nodular growth pattern, and a uniform population of cells of ML might mimic extraskeletal myxoid chondrosarcoma 21 and epithelioid hemangioendothelioma. 22 Although not a consistent reaction, positivity with S-100 helps in separating ML from extraskeletal myxoid chondrosarcoma and epithelioid hemangioendothelioma. 23 Expression of endothelial markers, including CD31 and CD34 and occasionally cytokeratin, distinguishes epithelioid hemangioendothelioma from ML. 22, 24 ML might be mistaken for low-grade myxofibrosarcoma because of the vascular stroma of the latter. 25 The vessels of low-grade myxofibrosarcoma characteristically are curvilinear, and the cells vary from stellate to spindle, in contrast to the relatively uniform cells of ML. 25 Nonlipogenic cellular ML might be difficult to differentiate from neuroendocrine tumors, melanoma, and the different components of small round cell tumors. The use of cytokeratin, neuroendocrine markers (synaptophysin and chromogranin), HMB-45, MART-1, and lymphoid markers helps categorize these neoplasms.
Cytogenetic study is an important ancillary test. The diagnosis of ML can be suggested by demonstration of t(12;16) (q13;p11) that fuses the CHOP and TLS genes present in more than 90% of these cases 26, 27 or t(12;22)(q13;q12), in which the CHOP gene pairs with the EWS (Ewing sarcoma) gene present in the remaining 10%. 27 In view of the pleomorphic, often nonlipogenic histologic features of metastatic PL, primary and other secondary tumors of the lungs such as MFH and spindle cell neoplasms comprised of carcinomas and sarcomas including melanoma enter the wide array of differential diagnoses. 6, 23, 28 Based on our cases, prolonged disease-free survival is rare for PL after pulmonary metastasectomy. PL has a shorter interval to pulmonary and extrapulmonary metastasis than DDL and ML. Despite excision of primary and metastatic disease and adjuvant treatment, disease progression in terms of metastasis is the usual clinical course. Local recurrence also is common for PLs arising in deep-seated locations such as retroperitoneum and mediastinum. 6, 28 The tumor grade and histologic features of primary PL, however, were reported not to affect patient outcome. 28 Most of the lipoblasts of PL and the nonlipoblastic elements to some extent are immunoreactive to S-100 protein. 23, 29 Nonlipoblastic differentiation may express expected antigens such as smooth muscle actin and desmin for smooth muscle differentiation, and cytokeratin and epithelial membrane antigen for epithelioid type, 23 but this is not an invariable reaction. 28 The cytogenetic alterations of PL are multiple and complex, 26 unlike those found in ALT/WDL and DDL and in ML and RCL. 26, 27 Recently, a comparative genomic hybridization study detected recurrent chromosomal imbalances with distinct patterns of gains and losses of chromosomes more frequently seen in PL than in DDL. 30 However, these results raise the possibility of not-careful morphologic discrimination between these 2 entities.
All metastatic DDLs in this series had high-grade histologic features, mainly those of an undifferentiated pleomorphic sarcoma, MFH type. A few of the heterologous elements previously described 31 also were present, including rhabdomyosarcomatous and osteosarcomatous differentiation. Because of the similarity with other sarcomas, definitive diagnosis can be established only by clinicopathologic correlation, which is important because DDLs have been reported to follow a less aggressive clinical course than high-grade sarcomas such as PLs and undifferentiated pleomorphic sarcomas (MFH). 7, [32] [33] [34] Both PL and DDL tumors have a tendency to involve the lungs more than any other organs in their spread, in contrast to ML, which favors extrapulmonary sites, [3] [4] [5] [6] [7] 18 including other soft tissue sites and bone. In most of our PL and DDL cases, the tumors in the lung were the first evidence of metastatic disease, and in about half of these cases, the lung was the only site of metastasis. In this series, the PL cases had shorter intervals to lung metastasis than DDL cases, which is in agreement with some published reports. 3, 4, 6 Histologically, the aggressive features of metastatic PL and DDL also were noted. Invasive clusters or scattered single neoplastic cells extended into the lung parenchyma at the interface of the tumor and lung parenchyma. Reactive changes such as alveolar hyperplasia that were seen with regularity in ML were noted rarely. Other histologic evidence of aggressiveness
